Vladimir E Ivanov

Title: Innovations of Vladimir E Ivanov

Introduction

Vladimir E Ivanov is a notable inventor based in Fremont, California, recognized for his contributions to biotechnology. He holds a total of four patents, showcasing his innovative approach to developing transgenic animals for medical applications. His work primarily focuses on producing specific isotypes of human antibodies, which has significant implications for therapeutic treatments.

Latest Patents

One of his latest patents is titled "Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions." This invention provides fully human antibodies in a transgenic animal of a desired isotype in response to immunization with virtually any desired antigen. The human immunoglobulin heavy chain transgene in these animals comprises a human constant region gene segment linked to switch segments from a different heavy chain isotype. This innovative approach allows for the production of antibodies that are tailored to specific medical needs. Another significant patent involves "Transgenic animals bearing human Ig light chain genes," which relates to methods and compositions for creating transgenic animals that incorporate human light chain loci. This invention further enhances the potential for developing therapeutic antibodies derived from these transgenic animals.

Career Highlights

Throughout his career, Ivanov has worked with prominent companies in the biotechnology sector, including Amgen Fremont Inc. and Abgenix, Inc. His experience in these organizations has contributed to his expertise in the field and has facilitated the advancement of his innovative projects.

Collaborations

Ivanov has collaborated with notable professionals in his field, including Larry L Green and C Geoffrey Davis. These collaborations have likely enriched his research and development efforts, leading to significant advancements in biotechnology.

Conclusion

Vladimir E Ivanov's work in the field of biotechnology, particularly in the development of transgenic animals for antibody production, highlights his innovative spirit and dedication to advancing medical science. His contributions continue to pave the way for future breakthroughs in therapeutic treatments.